Insights On CONTRACT PHARMA MANUFACTURING

1. Selecting A Test Method For Your Container System 8/21/2026

   Selecting CCIT requires matching methods like vacuum decay to product traits. Assess liquid conductivity, headspace, and lifecycle risks to build a compliant leak-detection strategy.

2. From Lipids To Launch: End-To-End Therapy Development 8/20/2026

   Explore integrated capabilities spanning lipid manufacturing, nanoparticle formulation, and more with support designed to move complex therapies from preclinical development through commercialization.

3. Annex-1 Compliant Robotic Aseptic Powder Fill/Finish Solution 8/20/2026

   Automated isolators bring precision to clinical powder fill-finish operations. By reducing batch variability and contamination risks, they deliver accurate dosing and speed up clinical trials.

4. Integrated QC As A Development Strategy: Reducing Late-Stage Analytical Risk 8/20/2026

   Learn how early QC integration, proactive analytical risk management, and cross-functional collaboration can improve validation readiness, reduce development surprises, strengthen release testing predictability, and help protect critical clinical manufacturing timelines.

5. Accelerating Phase: Supply Without Sacrificing Discipline 8/20/2026

   Faster clinical supply delivery starts with the right strategy. Explore how planning, collaboration, communication, and quality systems keep programs on track.

6. A Unified ELN And Inventory Model for Development-To-Manufacturing Continuity 8/20/2026

   Discover how integrated digital systems can improve traceability, inventory control, compliance, and knowledge management by connecting experimental data, materials, equipment, and sample histories within a single, searchable platform.

7. Risk-Based Spray Drying Scale-Up: From Early Feasibility To Commercial Control Strategy 8/20/2026

   Discover how science, modeling, risk assessment, and DoE turn spray-dried dispersion scale-up from trial-and-error transfer into a predictable, robust path to commercial manufacturing.

8. A Positive GMP Experience: Replacing Functional Handoffs With Project-Based Execution 8/20/2026

   Explore strategies for creating a stronger GMP culture through effective quality practices, collaboration, training, and continuous improvement. Learn how positive compliance experiences can support operational excellence, reduce risk, and strengthen manufacturing performance.

9. Small-Scale Prototyping with Scale in Mind: Building Drug Product Robustness Earlier 8/20/2026

   Learn how intentional small-scale development workflows can reduce scale-up risk by improving process understanding, strengthening formulation robustness, identifying critical quality attributes early, and creating a more predictable path from prototype to clinical manufacturing.

10. SEDDS: Improving Oral Bioavailability Of Poorly Soluble Compounds 8/20/2026

    Nearly 90% of marketed drugs have poor water solubility. Learn how self-emulsifying drug delivery systems (SEDDS) resolve oral bioavailability failures across BCS Class II and IV compounds.